Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Two simple approaches for validating a binary surrogate endpoint using data from multiple trials.

Stuart G Baker1

  • 1Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD 20892-7354, USA. sb16i@nih.gov

Statistical Methods in Medical Research
|February 21, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostate cancer screening: Decision-making when MRI results are inconclusive for cancer (PI-RADS 3).

Urologic oncology·2026
Same author

Adjusting for non-compliance and contamination with a more plausible assumption.

Journal of medical screening·2026
Same author

The efficient stored specimen design for evaluating multiple screening technologies: Application to multicancer detection tests.

Journal of medical screening·2025
Same author

Minimum test tradeoff applied to uterine artery pulsatility index for antepartum prediction of preeclampsia.

Pregnancy hypertension·2025
Same author

The Role of the Extracellular Matrix in Cancer Prevention.

Cancers·2025
Same author

Letter to the editor regarding "Early detection of pancreatic cancer: Study design and analytical considerations in biomarker discovery and early phase validation studies".

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2025
Same journal

A joint model for a longitudinal outcome and a progressive multistate model under a mixed observation scheme.

Statistical methods in medical research·2026
Same journal

Efficient semi-supervised estimation of optimal individualized treatment regimes with survival outcome.

Statistical methods in medical research·2026
Same journal

Asymptotic online FWER control for dependent test statistics.

Statistical methods in medical research·2026
Same journal

Regression analysis of misclassified current status data with potentially unknown test accuracy.

Statistical methods in medical research·2026
Same journal

Bayesian multivariate linear mixed-effects models with varied association structures.

Statistical methods in medical research·2026
Same journal

Inference about the ratio of age-standardized rates between two overlapping populations.

Statistical methods in medical research·2026
See all related articles

This study validates surrogate endpoints using two methods for colon cancer trials. Both methods showed good performance, supporting the use of surrogate endpoints for predicting true outcomes and potentially enabling accelerated drug approval.

Area of Science:

  • Biostatistics
  • Clinical Trials
  • Oncology

Background:

  • Surrogate endpoints predict true clinical outcomes but require validation.
  • Existing validation methods are limited.
  • Accurate validation is crucial for drug development and approval.

Purpose of the Study:

  • To introduce and evaluate two novel validation methods for surrogate endpoints.
  • To assess the reliability of surrogate endpoints in early and advanced colorectal cancer trials.
  • To explore the potential of validated surrogate endpoints for accelerated regulatory approval.

Main Methods:

  • An estimation method was developed, building on previous work, to predict true endpoint effects using surrogate endpoint data from multiple trials.
  • A new hypothesis testing method was introduced, utilizing the z-statistic for surrogate endpoints with an adjusted critical value.

Related Experiment Videos

  • Both methods were applied to two datasets comprising 10 randomized trials each for early and advanced colorectal cancer.

    • Main Results:

    • The estimation method demonstrated good performance in predicting intervention effects on true endpoints.
    • The hypothesis testing method also showed good performance, with surrogate endpoints accurately reflecting true endpoint outcomes.
    • Both validation approaches confirmed the reliability of the chosen surrogate endpoints in the studied cancer types.

    Conclusions:

    • The proposed validation methods provide a robust framework for assessing surrogate endpoints.
    • Validated surrogate endpoints can reliably predict clinical benefit, supporting their use in drug evaluation.
    • These methods may facilitate accelerated approval pathways for new cancer therapies.